loadpatents
name:-0.025848865509033
name:-0.015872001647949
name:-0.0012290477752686
NEWLANDER; Kenneth Allen Patent Filings

NEWLANDER; Kenneth Allen

Patent Applications and Registrations

Patent applications and USPTO patent grants for NEWLANDER; Kenneth Allen.The latest application filed is for "enhancer of zeste homolog 2 inhibitors".

Company Profile
0.17.24
  • NEWLANDER; Kenneth Allen - Collegeville PA
  • Newlander; Kenneth Allen - West Chester PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enhancer Of Zeste Homolog 2 Inhibitors
App 20180162845 - BRACKLEY, III; James A. ;   et al.
2018-06-14
Enhancer Of Zeste Homolog 2 Inhibitors
App 20170334891 - KNIGHT; Steven David ;   et al.
2017-11-23
Enhancer of zeste homolog 2 inhibitors
Grant 9,790,212 - Blackledge, Jr. , et al. October 17, 2
2017-10-17
Enhancer Of Zeste Homolog 2 Inhibitors
App 20170029412 - BLACKLEDGE, JR.; Charles William ;   et al.
2017-02-02
Enhancer of zeste homolog 2 inhibitors
Grant 9,505,745 - Blackledge, Jr. , et al. November 29, 2
2016-11-29
Indoles
Grant 9,402,836 - Brackley, III , et al. August 2, 2
2016-08-02
Enhancer of Zeste Homolog 2 inhibitors
Grant 9,382,234 - Knight , et al. July 5, 2
2016-07-05
Enhancer Of Zeste Homolog 2 Inhibitors
App 20160102083 - BLACKLEDGE, JR.; Charles William ;   et al.
2016-04-14
Indoles
App 20150313887 - BRACKLEY, III; James ;   et al.
2015-11-05
Enhancer Of Zeste Homolog 2 Inhibitors
App 20150307480 - KNIGHT; Steven David ;   et al.
2015-10-29
Azaindazoles
Grant 9,073,924 - Burgess , et al. July 7, 2
2015-07-07
Enhancer Of Zeste Homolog 2 Inhibitors
App 20150126522 - Burgess; Joelle Lorraine ;   et al.
2015-05-07
Azaindazoles
App 20140343056 - Burgess; Joelle Lorraine ;   et al.
2014-11-20
Quinoline Derivatives As Pi3 Kinase Inhibitors
App 20140296224 - ADAMS; Nicholas D. ;   et al.
2014-10-02
Indoles
Grant 8,765,792 - Knight , et al. July 1, 2
2014-07-01
Indoles
App 20130245016 - Knight; Steven David ;   et al.
2013-09-19
Quinoline derivatives as P13 kinase inhibitors
Grant 8,404,837 - Adams , et al. March 26, 2
2013-03-26
Quinoline Derivatives As Pi3 Kinase Inhibitors
App 20120165321 - Adams; Nicholas D. ;   et al.
2012-06-28
Pyridosulfonamide Derivatives As P13 Kinase Inhibitors
App 20100311736 - Adams; Nicholas D. ;   et al.
2010-12-09
Pyridopyrimidine Derivatives As P13 Kinase Inhibitors
App 20100204222 - Newlander; Kenneth Allen ;   et al.
2010-08-12
Quinazoline Derivatives As P13 Kinase Inhibitors
App 20100179144 - Adams; Nicholas D. ;   et al.
2010-07-15
Azaindole inhibitors of Aurora kinases
Grant 7,605,266 - Dhanak , et al. October 20, 2
2009-10-20
Azaindole inhibitors of aurora kinases
Grant 7,495,102 - Sarpong , et al. February 24, 2
2009-02-24
Quinazoline Derivatives As P13 Kinase Inhibitors
App 20090018131 - ADAMS; Nicholas D. ;   et al.
2009-01-15
Azaindole inhibitors of aurora kinases
App 20080306120 - Dhanak; Dashyant ;   et al.
2008-12-11
Quinoline Derivatives As Pi3 Kinase Inhibitors
App 20080300239 - Adams; Nicholas D. ;   et al.
2008-12-04
Azaindole inhibitors of aurora kinases
Grant 7,419,988 - Dhanak , et al. September 2, 2
2008-09-02
Compounds, Compositions, and Methods
App 20080176830 - Adams; Nicholas D. ;   et al.
2008-07-24
Azaindole Inhibitors Of Aurora Kinases
App 20080081808 - Sarpong; Martha A. ;   et al.
2008-04-03
Azaindole Inhibitors Of Aurora Kinases
App 20080004308 - Dhanak; Dashyant ;   et al.
2008-01-03
Compounds, compositions and methods
App 20070254870 - Bergnes; Gustave ;   et al.
2007-11-01
Azaindole inhibitors of aurora kinases
Grant 7,282,588 - Dhanak , et al. October 16, 2
2007-10-16
Azaindole Inhibitors Of Aurora Kinases
App 20070149561 - DHANAK; Dashyant ;   et al.
2007-06-28
Compounds, compositions and methods
Grant 7,208,487 - Bergnes , et al. April 24, 2
2007-04-24
Compounds, compositions and methods
App 20060052360 - Bergnes; Gustave ;   et al.
2006-03-09
Compounds
Grant 5,908,960 - Newlander June 1, 1
1999-06-01
Bicyclic fibrinogen antagonists
Grant 5,693,636 - Bondinell , et al. December 2, 1
1997-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed